Quick Answer
REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Total Assets of $15.92 million for fiscal year 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $15.92M | +2.7% |
| 2024 | $15.50M | -34.6% |
| 2023 | $23.70M | +25.2% |
| 2022 | $18.92M | -39.7% |
| 2021 | $31.40M | +258.4% |
| 2020 | $8.76M | -85.6% |
| 2020 | $61.02M | +2346892.7% |
| 2019 | $2.6K | -100.0% |
| 2019 | $65.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.33M | +87.8% | +23.2% |
| June 30, 2025 | $11.63M | +44.5% | +64.4% |
| March 31, 2025 | $7.08M | -47.6% | -54.4% |
| December 31, 2024 | $15.50M | -34.6% | +103.2% |
| September 30, 2024 | $7.63M | +41.6% | -5.3% |
| June 30, 2024 | $8.05M | -32.0% | -40.3% |
| March 31, 2024 | $13.50M | +4.6% | -43.1% |
| December 31, 2023 | $23.70M | +25.2% | +340.0% |
- REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +2.7% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, REVIVA PHARMACEUTICALS HOLDINGS, INC.’s total assets has declined by 75.7% (from $65.65 million to $15.92 million).
- The most recent figure is from REVIVA PHARMACEUTICALS HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: